NEW YORK, June 14, 2022 /PRNewswire/ — The law firm Klein announces that a class action lawsuit has been filed on behalf of shareholders of CareDx, Inc. (NASDAQ: CDNA) alleging that the company violated federal securities laws.
This lawsuit is on behalf of all persons or entities who have purchased common stock of CareDx between February 24, 2021and May 5, 2022.
Lead Applicant Deadline: July 22, 2022
No obligation or cost to you.
Learn more about your recoverable losses in CDNA:
NEWS from CareDx, Inc. – ADNC NEWS
CLASS ACTION CASE DETAILS: The filed complaint alleges that CareDx, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the defendants engaged in a variety of improper and unlawful revenue-inflating schemes and demand for testing services, including pushing a surveillance protocol through inaccurate marketing materials, offering outlandish inducements or bribes to doctors and other providers, and inappropriately bundling expensive testing services with other blood tests as part of the company’s RemoTraC service for remote and home blood sampling; (2) these practices, and others, have subjected CareDx to undisclosed risk of regulatory scrutiny; (3) these practices artificially inflated the Company’s reported testing services revenues throughout the Class Period; and (4) therefore, defendants’ positive statements about the Company’s business, operations and prospects were materially false and misleading and/or lacked reasonable basis at all relevant times.
WHAT THIS MEANS FOR YOU AS A SHAREHOLDER: If you have suffered a loss in CareDx, you have until July 22, 2022 ask the court to obtain the status of principal plaintiff. Your ability to participate in any collection does not require you to serve as the lead plaintiff.
AT NO CHARGE TO YOU: If you purchased CareDx titles during the relevant period, you may be entitled to compensation without payment of out-of-pocket costs.
HOW TO PROTECT YOUR FINANCIAL INTERESTS: For more information on the CDNA trial, please contact J. Klein, Esq. by phone at 212-616-4899 or click on this link: https://www.kleinstocklaw.com/pslra-1/caredx-inc-loss-submission-form?id=28442&from=4.
ABOUT KLEIN LAW FIRM
J. Klein, Esq. represents investors and participates in securities litigation involving financial fraud across the country. Klein Law Firm is a litigation firm with experience in a wide range of areas, including securities law, corporate finance and commercial litigation. Since 2011, our experienced lawyers have achieved superior results for our clients with a personalized approach. Lawyer advertisement. Prior results do not guarantee similar results.
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
New York, NY 10118
Telephone: (212) 616-4899
View original content: https://www.prnewswire.com/news-releases/cdna-alert-the-klein-law-firm-announces-a-lead-plaintiff-deadline-of-july-22-2022-in – the-collective-action-filed-in-the-name-of-caredx-inc-shareholders-301567184.html
SOURCE Klein Law Firm